Program
Download final Conference Program with all selected presentations (1.3 Mb; last update October 24, 2014)
Download complete Conference Program and Abstracts (5.2 Mb; last update January 5, 2015)
Download GSCN Conference 2014 Report (2.1 MB)
| Monday | Tuesday | Wednesday |
Monday, November 3rd
| 11:00 – 12:00 | Registration and light lunch |
| Opening | |
|
12:00 – 12:05 |
Welcome to the German Cancer Research Center (DKFZ) Ottmar Wiestler (Chairman and Scientific Director, DKFZ) |
| 12:05 – 12:15 | Andreas Trumpp (Acting President, GSCN) |
| 12:15 – 12:30 | Opening remarks Bärbel Brumme-Bothe (Department Head “Life Sciences”, BMBF) |
| 12:30 – 13:15 |
Keynote lecture I Cancer Stem Cells Eduard Batlle; Institute for Research in Biomedicine Barcelona, Spain (chair: Andreas Trumpp) supported by Eppendorf AG |
| 13:15 – 14:00 | Keynote lecture II Myocardial regeneration by ESC-derived cardiac progenitors Philippe Menasché; University of Paris Descartes, Paris, France (chair: Ulrich Martin) |
| 14:00 – 14:30 |
Coffee break and industry exhibition |
| Concurrent scientific working group session I | |
| Lecture hall: |
Stem cells in regenerative therapies I (chair: Ulrich Martin/Hans-Dieter Volk) |
| 14:30 – 14:50 | Stem cells in regenerative therapies – Introduction Ulrich Martin; Rebirth/Hannover Medical School |
| 14:50 – 15:05 | T01 – Intranasal delivery of migratory neural stem/progenitor cells: A non-invasive passage to therapeutically target intracerebral brain tumors Nils Ole Schmidt; University Medical Center, Hamburg-Eppendorf |
| 15:05 – 15:20 | T02 – MicroRNA-181a promotes human neuronal differentiation by down-regulating genes involved in neural stem cell maintenance Laura Stappert; Institute of Reconstructive Neurobiology, Bonn |
| 15:20 – 15:35 | T03 – Pulmonary transplantation of multipotent- or pluripotent-stem cell derived macrophages as a novel treatment option for pulmonary alveolar proteinosis Nico Lachmann; Hannover Medical School |
| 15:35 – 15:50 | T04 – Human iPSC-derived MSC-like progenitor cells: functional differences from primary MSCs affecting their use in cartilage regenerative medicine Solvig Diederichs; University Hospital Heidelberg |
| 15:50 – 16:00 | Group discussion |
| Room K1: | Stem cells in disease: cancer stem cells (chair: Thomas Brabletz/ Andreas Trumpp) |
| 14:30 – 14:50 | Concepts of cancer stem cells – Introduction Andreas Trumpp; German Cancer Research Center, Heidelberg |
| 14:50 – 15:05 | T05 – Shp2 Signaling is essential to the suppression of senescence in mammary gland cancer stem cells in mice Linxiang Lan; Max Delbrück Center, Berlin |
| 15:05 – 15:20 | T06 – Humanization of mouse models for human breast cancer using mesenchymal stem cells Maxine Silvestrov; Experimental Pharmacology & Oncology (EPO) GmbH, Berlin |
| 15:20 – 15:35 | T07 – Targeting the kinome to induce differentiation in human breast cancer stem cells Jochen Maurer; University Medical Center Freiburg |
| 15:35 – 15:50 | T08 – CD151+ cells drive tumor-initiation, hierarchical growth and proliferation-associated signaling in patient-derived models of serous ovarian cancer Franziska Zickgraf; German Cancer Research Center, Heidelberg |
| 15:50 – 16:00 | Group discussion |
| Room K 2: | Computational stem cell biology (chair: Georg Fuellen/Ingo Roeder) |
| 14:30 – 14:45 | Computational stem cell biology – Overview and introduction Ingo Roeder; Dresden University of Technology |
| 14:45 – 14:55 | T09 – What makes stem cells move? Studying stem cell migration in vitro (back-to-back presentation with T10) Michael Ansorge; Leipzig University |
| 14:44 – 15:05 | T10 – What makes stem cells move? Studying stem cell migration in silico (back-to-back presentation with T09) Axel Krinner; Dresden University of Technology |
| 15:05 – 15:20 | T11 – Characterizing transcriptional cell-to-cell heterogeneities during stem cell differentiation Fabian Theis; Helmholtz Center Munich |
| 15:20 – 15:35 | T12 – A network-based strategy to direct cell fate determination Antonio del Sol; Luxembourg Center for Systems Biomedicine |
| 15:35 – 15:50 | T13 – Computational identification of pluripotency networks Maryam Nazarieh; Saarland University, Saarbrücken |
| 15:50 – 16:00 | Group discussion |
| ZMBH (ground floor): | Somatic stem cells (chair: Thomas Braun/Ana Martin-Villalba) |
| 14:30 – 14:50 | Studies on somatic stem cells – An introduction Thomas Braun; Max Planck Inst. f. Heart and Lung Res., Bad Nauheim |
| 14:40 – 15:05 | T14 – The RNA helicase DDX6 regulates cell-fate specification in neural stem cells via miRNAs Sarah Nicklas; Luxembourg Center for Systems Biomedicine |
| 15:05 – 15:20 | T15 – Angiogenesis controls neural stem cell expansion by regulating tissue oxygenation and HIF signaling Christian Lange; VIB KU Leuven Campus, Belgium |
| 15:20 – 15:35 | T16 – Regulation of asymmetric/symmetric stem cell division in human epidermis Katharina Nöske; German Cancer Research Center, Heidelberg |
| 15:35 – 15:50 | T17 – Clonal heterogeneity within the exocrine pancreas Damian Wollny; German Cancer Research Center, Heidelberg |
| 15:50 – 16:00 | Group discussion |
| 16:00 – 16:15 | Coffee break/industry exhibition |
| 16:15 – 18:15 | Poster session I: P001 – P097 supported by Fluidigm Europe B.V. |
| (posters will be displayed in the tent) P001 – P017: Pluripotency and embryonic stem cells P018 – P038: Programing and Reprograming P039 – P061: Stem cells in development P062 – P072: Somatic stem cells (posters will be displayed in front of room K 1+2) P073 – P097: Hematopoietic stem cells Even numbers: please present your poster from 16:15 – 17:15 Uneven numbers: please present your poster from 17:15 – 18:15 |
|
| 18:15 – 19:15 | Dinner |
| 19:15 – 20:45 |
GSCN General Membership Meeting |
| 20:45 – 21:30 |
Get-together |
Top |
Tuesday, November 4th
| Concurrent scientific working group session II |
|
| Lecture hall: |
Stem cells in disease modeling and drug development (chair: Oliver Brüstle/Karl-Ludwig Laugwitz) |
| 09:00 – 09:20 |
The use of stem cells in disease modeling and drug development – Overview Oliver Brüstle; Institute of Reconstructive Neurobiology, Bonn |
| 09:20 – 09:35 | T18 – Probing mitochondrial DNA disorders using iPSC-derived neural progenitors Alessandro Prigione; Max Delbrück Center, Berlin |
| 09:35 – 09:50 | T19 – Modeling Dravet syndrome in iPS cell-derived neurons Matthias Hebisch; Institute of Reconstructive Neurobiology, Bonn |
| 09:50 – 10:05 | T20 – The functionality of stem cell derived neurons: How to define it? Sebastian Illes; Inst. of Molecular Reg. Medicine, Salzburg, Austria |
| 10:05 – 10:20 | T21 – Modeling and pharmacological rescue of ion channel diseases enabled by improved cardiac induction of human pluripotent stem cells in 2D and 3D formats Boris Greber; Max Plank Institute for Molecular Biomedicine, Münster |
| 10:20 – 10:30 | Group discussion |
| Romm K 1+2: | Pluripotency and embryonic stem cells (chair: James Adjaye/Mathias Treier) |
| 09:00 – 09:20 | Pluripotency and embryonic stem cells: Introduction and Overview James Adjaye; University Hospital of Düsseldorf |
| 09:20 – 09:35 | T22 – Primate-specific endogenous retrovirus driven transcription defines naïve-like stem cells Jichang Wang; Max Delbrück Center, Berlin |
| 09:35 – 09:50 | T23 – A novel lncRNA-protein interaction characterizes mouse embryonic stem cell fate Debojyoti Chakraborty; Dresden University of Technology |
| 09:50 – 10:05 | T24 – NANOG and CDX2 Pattern distinct subtypes of human mesoderm during Exit from Pluripotency Sasha Mendjan; Cambridge Stem Cell Institute, United Kingdom |
| 10:05 – 10:20 | T25 – Insights from the streak: identification of novel genes associated with germ-layer formation and mesendoderm differentiation Cantas Alev; RIKEN Center for Developmental Biology, Kobe, Japan |
| 10:20 – 10:30 | Group discussion |
| ZMBH (ground floor): | Stem cells in development (chair: Jan Lohmann/Francesca Spagnoli) |
| 09:00 – 09:15 | Stem cells in development – An overview Jan Lohmann; Centre for Organismal Studies Heidelberg |
| 09:15 – 09:30 | T26 – Tet-dependent processing of 5-methylcytosine protects DNA methylation canyons against hypermethylation Achim Breiling; German Cancer Research Center, Heidelberg |
| 09:30 – 09:45 | T27 – PIEZO2 is required for mechanotransduction in human ES-cell-derived touch receptors Katrin Schrenk-Siemens; University of Heidelberg |
| 09:45 – 10:00 | T28 – Transcriptional and epigenetic dynamics underlying cell lineage commitment Filippo M. Cernilogar; Ludwig Maximilian University, Munich |
| 10:00 – 10:15 | T29 – The histone 3 lysine 4 methyltransferase Mll2 primes the Nxt2 promoter for neural differentiation Katrin Neumann; Dresden University of Technology |
| 10:15 – 10:30 | T30 – Signals from the injury niche increase fate potential of adult neural stem cells Enric Llorens Bobadilla; German Cancer Research Center, Heidelberg |
| 10:30 – 11:15 |
Coffee break/industry exhibition |
| Industry session: “Technologies from GSCN industry partners” | |
| Lecture hall: |
Main supporters |
| 11:15 – 11:20 | Introduction (Andreas Trumpp) |
| 11:20 – 11:50 | C01 – High throughput screening using iPSC-based models Jared Sterneckert; CRT Dresden, representing PeproTech GmbH |
| 11:50 – 12:20 | C02 – Controlling expansion and cardiomyogenic differentiation of human pluripotent stem cells in scalable suspension culture Robert Zweigerdt; MH Hannover, representing Eppendorf AG |
| 12:20 – 12:50 |
C03 – Raw materials in the manufacture of advanced therapies medicinal products: Quality attributes and quality assurance Bernd Leistler; CellGenix GmbH |
| Room K 1+2: |
Supporters |
| 11:15 – 11:20 | Introduction (Michael Cross) |
| 11:20 – 11:50 | C04 – Efficient Neural and Cardiac Differentiation Systems for iPSC Mohan C. Vemuri; Life Technologies GmbH |
| 11:50 – 12:20 | C05 – Cell-based gene delivery leverages conventional immunotherapy for cancer; Treatment of advanced gastrointestinal cancer in a phase I/II trial with modified autologous MSC_apceth_101 Volker Scherhammer; apceth GmbH & Co. KG |
| 12:20 – 12:50 | C06 – Scalable enzyme-free protocols for the isolation and maintenance of human induced pluripotent stem cells without mechanical colony scraping Alexandra Blak; STEMCELL Technologies SARL |
| ZMBH (ground floor): |
Supporters |
| 11:15 – 11:20 | Introduction (Torsten Tonn) |
| 11:20 – 11:50 | C07 – The future is counting – Digital analysis of RNA, DNA and protein biomarkers Maik Pruess; NanoString Technologies Germany GmbH |
| 11:50 – 12:20 | C08 – Primate iPS cells as tools for evolutionary analyses Wolfgang Enard; Ludwig Maximillians University, Munich; representing Fluidigm Europe B.V. |
| 12:20 – 12:50 |
C09 – Building bridges from research to therapy: A roadmap for the successful generation of clinical-grade iPSCs Thomas Fellner; Lonza Cologne GmbH |
| 12:50 – 14:30 |
Lunch buffet, industry exhibition and poster viewing supported by STEMCELL Technologies SARL |
| 13:15 – 14:15 | Room K 1+2: Explaining science and motivating people – Outreach materials for stem cell research (Tobias Cantz/Ira Herrmann) |
| Concurrent strategic working group session A | |
| Lecture hall: |
Career development (chairs: Hartmut Geiger/Insa Schröder) |
| 14:30 – 14:45 | Careers in industry, Andreas Bosio; Miltenyi GmbH, Berg. Gladbach |
| 14:45 – 15:00 | Careers in science administration, Hella Lichtenberg; DLR Bonn |
| 15:00 – 15:15 | Careers in academia, Hartmut Geiger/Insa Schröder |
| 15:15 – 15:30 | Panel discussion |
| Room K 1+2: | Clinical trials and regulatory affairs I (chair: Andreas Kurtz/Torsten Tonn/Hans-Dieter Volk) supported by apceth GmbH & Co. KG |
| 14:30 – 14:50 | Development of iPS cell-based cardiac therapy Ulrich Martin, MH Hannover |
| 14:50 – 15:10 | Regulatory challenges of stem cell-based medicinal products Egbert Flory; Paul Ehrlich Institute, Langen |
| 15:10 – 15:30 | Group/panel discussion |
| ZMBH (ground floor): | Large scale banking of human pluripotent stem cells – workshop (chair: Andreas Kurtz/Joana Namorado) |
| 14:30 – 14:45 | Biomedical applications of iPS cell technology Angel Raya; CMRB Barcelona |
| 14:45 – 15:00 | The need for large-scale iPSC collections – a pharma perspective Alex Gutteridge; Pfizer |
| 15:00 – 15:15 | Delivery of human pluripotent stem cells for therapy: Phase IV of the UK Stem Cell Bank Project Lyn Healy; UK Stem Cell Bank, South Mimms, U.K. |
| 15:15 – 15:30 | The relaunch of the human pluripotent stem cell registry (hESCreg) Andreas Kurtz; BCRT Berlin |
| 15:30 – 15:45 |
Short break |
| Concurrent strategic working group session B | |
| Lecture hall: |
Stem cell technologies (chair: Andreas Bosio/Frank Emmrich) |
| 15:45 – 15:50 | Introduction: Andreas Bosio, Miltenyi GmbH, Berg. Gladbach |
| 15:50 – 16:05 | Methods of genetic engineering Claudio Mussolino; University of Freiburg |
| 16:05 – 16:20 | Reprogramming technologies Micha Drukker; Helmholtz Center Munich |
| 16:20 – 16:35 | Methods of laser cell printing Boris Chichkov; Laser Center Hannover (LZH) |
| 16:35 – 16:45 | Group/panel discussions |
| Room K 1+2: | Clinical trials and regulatory affairs II (chair: Andreas Kurtz/Torsten Tonn/Hans-Dieter Volk) |
| 15:45 – 16:05 | Placenta expanded mesenchymal (PLX) cells– preclinical data for preparing clinical trials Lena Pinzur; PluriStem Therapeutics Inc., Haifa, Israel |
| 16:05 – 16:25 | PLX cells – from preclinical to clinical studies – what did we learn so far from biomarker studies? Hans-Dieter Volk; Berlin-Brandenburg Center for Reg. Therapies (BCRT) |
| 16:25 – 16:45 | Panel discussions |
| ZMBH (ground floor): | Funding opportunities for young and advanced scientists (chair: Hartmut Geiger/Albrecht Müller) |
| 15:45 – 16:30 | Funding opportunities of the DFG for stem cell scientists at various career stages Eckard Picht; German Research Foundation (DFG), Bonn |
| 16:30 – 16:45 | Group Discussion |
| 16:45 – 17:15 | Coffee break and industry exhibition |
| 16:46 – 17:45 | DKFZ Mensa: Meet-the-expert lunch: Stem cell technologies – genetic engineering (Claudio Mussolino) limited to 10 registered participants |
| 17:15 – 19:15 | Poster session II: P098 – P187 (posters will be displayed in the tent) P098 – P129: Stem cells in regenerative therapies P130 – P161: Stem cells in disease modeling and drug development (posters will be displayed in front of room K 1+2) P162 – P178: Stem cells in disease: Cancer stem cells P179 – P187: Computational stem cell biology Even numbers: please present your poster from 17:15 – 18:15 Uneven numbers: please present your poster from 18:15 – 19:15 |
| 19:15 – 20:00 | Free bus shuttle to networking evening (busses will depart from the DKFZ main entrance) |
| 20:00 – 01:00 |
Networking evening with dinner buffet at Schlosshotel “Molkenkur” Klingenteichstr. 31, 69117 Heidelberg (www.molkenkur.de) (Opening: Oliver Brüstle) (included in the registration fee) supported by CellGenix GmbH |
Top |
Wednesday, November 5th
| Concurrent scientific working group session III | |
| Lecture hall: |
Hematopoietic stem cells (chair: Anthony Ho/Claudia Waskow) |
| 09:00 – 09:20 | Introduction “Hematopoietic stem cells” Claudia Waskow; Technical University Dresden |
| 09:20 – 09:35 | T31 – Stroma-derived osteopontin regulates hematopoietic stem and progenitor cells function upon aging Novella Guidi; University of Ulm |
| 09:35 – 09:50 | T32 – Identification of regulatory networks in HSCs and their immediate progeny via integrated proteome, transcriptome, and DNA methylome analysis Daniel Klimmeck; German Cancer Research Center, Heidelberg |
| 09:50 – 10:05 | T33 – Kit deficiency regulates stable human hematopoietic stem cell engraftment in mice Susann Rahmig; Technical University Dresden |
| 10:05 – 10:20 | T34 – STAT5-regulated miRNA193b controls hematopoietic stem and progenitor cell expansion by fine tuning cytokine signaling Nadine Hätscher; University Hospital Frankfurt |
| 10:20 – 10:30 | Group discussion |
| Room K 1+2: | Programming and reprogramming (chair: Micha Drukker/Frank Edenhofer) |
| 09:00 – 09:15 | Introduction to re-programming Frank Edenhofer; University of Würzburg |
| 09:15 – 09:30 | T35 – Selective gene delivery into human iPS cells based on CD30-targeted lentiviral vectors Thorsten Friedel; Paul Ehrlich Institute, Langen |
| 09:30 – 09:45 | T36 – Generation of iPS cells from young vs. aged cell sources – influence of donor age on reprogramming efficiency and genetic stability of iPS clones Katarzyna Osetek; LEBAO/Hannover Medical School |
| 09:45 – 10:00 | T37 – Mesenchymal stem cells derived from iPS cells from aged individuals acquire fetal characteristics Lucas Spitzhorn; University Hospital of Düsseldorf |
| 10:00 – 10:15 | T38 – TRIM32, a dual player regulating the entry and exit from pluripotency Lamia’a Bahnassawy; University of Luxembourg |
| 10:15 – 10:30 | T39 – Robust generation of cardiomyocytes from human iPS cells requires precise modulation of Bmp and Wnt signaling Asifiqbal Kadari; Julius Maximilians University, Würzburg |
| DKFZ SR 4th floor: | Stem cells in regenerative therapies II (chair: Michael Cross/Frank H2.04.073 Emmrich) The meeting point for this session is at the registration desk! |
| 09:00 – 09:15 | Introduction to session II stem cells in regenerative therapies Michael Cross; University of Leipzig |
| 09:15 – 09:30 | T40 – Efficient generation of functionally defined iPSC-derived human neural stem/progenitor cells and oligodendrocytes Giacomo Frati; San Raffaele Scientific Institute, Milan, Italy |
| 09:30 – 09:45 | T41 – Aging affects the mesenchymal stem cell derived oligodendrogenic / remyelination activities: implication for a potential therapy of multiple sclerosis Francisco J. Rivera; Paracelsus Medical University, Salzburg, Austria |
| 09:45 – 10:00 | T42 – The european project REBORNE: Multipotent mesenchymal stromal cells and biomaterial for bone healing Alexander Erle; Ulm University Hospital |
| 10:00 – 10:15 | T43 – Identification, isolation and targeted inhibition of a fibroblast lineage responsible for scarring and cancer stroma Yuval Rinkevich; Stanford Institute for Stem Cell Biology and Regenerative Medicine, U.S.A. |
| 10:15 – 10:30 | T44 – Proofing the (Un)Proven: Proven or approved stem cell therapies – that is the question Bianca Büchner; Center for Ethics and Law in the Life Sciences (CELLS), Hannover |
| 10:30 – 11:00 | Coffee break and industry exhibition |
| Concurrent Workshops | |
| Lecture hall: | Clinical relevance of animal models in stem cell research and regenerative medicine (chair: Georg Duda/Frank Emmrich) (Workshop of the ‘Regenerative Medicine Initiative Germany (RMIG)’) |
| 11:00 – 11:20 | Introduction: Animal models in research for regenerative medicine Axel Haverich; Rebirth/Hannover Medical School |
| 11:20 – 11:30 | Cell transplantation into pre-clinical models of retinal degeneration Marius Ader; Center for Regenerative Therapies Dresden |
| 11:30 – 11:40 | Medical devices and the application of stem cells Konrad Kohler; zrm, Tübingen University Hospital |
| 11:40 – 11:50 | Regenerative medicine for an aging society: How relevant are our current animal models? Georg Duda; BCRT Berlin |
| 11:50 – 12:00 | Heterogeneity, age, comorbidities and the translational failure – can we do better in projecting from preclinical stem cell studies to clinical trials? Johannes Boltze; TRM Leipzig |
| 12:00 – 12:10 | Hurdles for clinical translation of regenerative stem cell therapy – lessons learned from the cardiac Phase III PERFECT multicenter trial Gustav Steinhoff; RTC Rostock |
| 12:10 – 12:30 | Panel discussion |
| Room K 1+2: | Big pharma and the stem cell field – matching expectations? (organizer: Oliver Brüstle/Ira Herrmann) (Workshop of the Stem Cell Network North Rhine Westphalia) Panel: Oliver Brüstle; LIFE & BRAIN GmbH, Bonn Ralf Heilker; Boehringer Ingelheim Pharma GmbH & Co. KG, Div. Research Germany Jörg Hüser; Bayer Pharma AG, Lead Discovery Wuppertal Bert Klebl; Lead Discovery Center GmbH, Dortmund Moderation: Ira Herrmann; Stem Cell Network NRW, Düsseldorf |
| ZMBH (ground floor): | Proceedings of the German Society for Stem Cell Research (GSZ e.V.) (chair: Jürgen Hescheler) Speaker: Jürgen Rohwedel; Lübeck, Robert David; Rostock; Tanja Waldmann; Konstanz, Bernd Denecke; RWTH Aachen |
| 12:30 – 12:45 | Short break |
| 12:45 – 13:30 | Keynote lecture III K3 – Molecular and cellular regulation of muscle stem cells during development and regeneration Shahragim Tajbakhsh; Institute Pasteur, Paris, France (Chair: Oliver Brüstle) |
| 13:30 – 15:00 |
Lunch buffet/industry exhibition supported by Nanostring Technologies Germany GmbH |
| 13:45 – 14:45 | Room K 1+2: Explaining science and motivating people – Outreach materials for stem cell research (Tobias Cantz/Ira Herrmann) |
| 13:45 – 14:45 | DKFZ Mensa: Meet-the-expert lunch: Stem cell technologies – laser printing (Boris Chichkov) and – reprogramming technologies (Micha Drukker) limited to 10 registered participants each |
| Closing ceremony |
|
| 15:00 – 15:15 | Poster award ceremonies and announcement of industry quiz winners (Daniel Besser; GSCN) supported by PeproTech GmbH |
| 15:15 – 15:30 | Outlook and closing remarks Incoming president: Thomas Braun |
| 15:30 – 16:15 | Keynote lecture IV – Joined session with the 6th BMBF symposium – Adult neural stem cells (chair: Magdalena Götz/Ana Martin-Villalba) K4 – Modeling human brain development and disease in 3D culture Jürgen Knoblich; Institute of Molecular Biotechnology (IMBA) Vienna, Austria supported by Life Technologies GmbH |
| 16:15 – 17:00 | K5 – Adult hippocampal neurogenesis: What are new neurons good for? And what is good for them? Amelia Eisch; UT Southwestern, Dallas, U.S.A. |
| 17:00 – 17:45 | K6 – A mechanism for the segregation of age in mammalian neural stem cells Sebastian Jessberger; University of Zurich, Switzerland |
| 17:45 – 18:30 | Coffee break and poster session GSCN satellite event |
| End of GSCN conference 2014 |
|
| |
|
| Announcements: | |
| 18:30 – 20:00 | Public outreach event of the GSCN in collaboration with the Ernst Schering Foundation and the DKFZ (in German) Stammzellen als Chance – Realität und Perspektiven Podiumsdiskussion zur aktuellen Forschung in Labor und Klinik Panel: Magdalena Götz (LMU München), Anthony Ho (Uni. Heidelberg), Andreas Trumpp (DKFZ) Moderation: Stefanie Seltmann (DKFZ) |
| 20:00 – 21:00 | Reception public outreach event |
| and | |
| November 6th, 2014 – GSCN Satellite Event: 6th BMBF Symposium – Adult neural stem cells The program of the satellite event is available at the reception desk. |
|
Top |
Supporters
© German Stem Cell Network (GSCN) e.V., 2014
Last updated 08/04/2014
Last updated 08/04/2014